Back in June, shares jumped 7% over the course of a week after the company received approval to buy medical device maker Synthes for $20 billion, resulting in upgrades from several Wall Street analysts. Since then, shares …
Read More:
10 stocks least addicted to the Fed's QE3 – Weekend Investor …
Tags: analysts, maker, medical, qd syringe systems, qdss, synthes, Syringes, wall